Vimarsana
Biggest News Aggregation in the World

Page 4 - Pulse Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pulse Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pulse Bioscience Today - Breaking & Trending Today

Pulse Biosciences Clarifies Details of Recent S-3 Filing - Vimarsana News

Pulse Biosciences Clarifies Details of Recent S-3 Filing

Pulse Biosciences, Inc. , a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology for the treatment of atrial fibrillation, today provided...

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2023 Earnings Call Transcript - Vimarsana News

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2023 Earnings Call Transcript

Operator: Greetings, and welcome to Pulse Biosciences' Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have had a fantastic week as stock increased 31%, and they haven't stopped buying - Vimarsana News

Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have had a fantastic week as stock increased 31%, and they haven't stopped buying

Key Insights Pulse Biosciences' significant insider ownership suggests inherent interests in company's expansion 76% of...

Source: yahoo.com
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results - Vimarsana News

Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary nanosecond pulsed field ablation technology for the treatment of atrial fibrillation, today announced financial results for... | May 11, 2023

Paragon 28 (NYSE:FNA) vs. Pulse Biosciences (NASDAQ:PLSE) Critical Contrast - Vimarsana News

Paragon 28 (NYSE:FNA) vs. Pulse Biosciences (NASDAQ:PLSE) Critical Contrast

Paragon 28 (NYSE:FNA – Get Rating) and Pulse Biosciences (NASDAQ:PLSE – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk and dividends. Profitability This table compares Paragon 28 and Pulse Biosciences’ […]